Clinical Trials Directory

Trials / Completed

CompletedNCT00875498

Intermittent Theta Burst Stimulation (iTBS) for the Treatment of Negative Symptoms in Schizophrenia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Hôpital le Vinatier · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether the iTBS is an effective treatment of the negative symptoms of schizophrenia.

Detailed description

This study will evaluate whether the intermittent Theta Burst Stimulation (iTBS), a new high frequency TMS protocol is efficient in the treatment of the Negative Symptoms of schizophrenia. Neuroimaging studies demonstrate that hypoactivity in the left dorsolateral prefrontal cortex (LDLPFC) was associated with negative symptoms. The investigators hypothesize that iTBS applied to LDLPFC will improve negative symptoms and will improve activity of the LDLPFC measured with Magnetic Resonance Spectroscopy (MRS).

Conditions

Interventions

TypeNameDescription
PROCEDUREactive iTBSIntermittent Theta Burst Stimulation (iTBS) over Left dorsolateral prefrontal cortex. 80% MT, 20 sessions of 6 minutes, 2 per day
PROCEDUREsham iTBSiTBS placebo (placebo coil)

Timeline

Start date
2008-11-01
Primary completion
2015-07-01
Completion
2015-07-01
First posted
2009-04-03
Last updated
2016-01-27

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00875498. Inclusion in this directory is not an endorsement.